Business Context and Reporting Period
This Form 8-K filing by Definitive Healthcare Corp. (DH) covers the period ending April 3, 2026. The report addresses a corporate governance event involving the termination of a material definitive agreement with a significant shareholder.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a legal agreement termination and does not contain financial performance data.
Material Changes
The primary material change reported is the permanent and irrevocable termination of the Nominating Agreement dated September 17, 2021, between Definitive Healthcare Corp. and SE VII DHC AIV, L.P. ("Spectrum"). Key details include:
- Resignation: Jeff Haywood, the director designated by Spectrum under the agreement, resigned from the Board of Directors on March 30, 2026.
- Termination: On April 3, 2026, the Company and Spectrum executed a termination agreement ending the Nominating Agreement in its entirety.
- Impact: Spectrum no longer holds the contractual right to designate a director nominee, regardless of its beneficial ownership percentage.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, outlook, management commentary on financial performance, or specific risk factors beyond the conclusion of the shareholder agreement. The document serves as a disclosure of the completed termination event.
Investor Verification Checklist
- Verify the current beneficial ownership percentage of SE VII DHC AIV, L.P. to assess remaining influence.
- Confirm the composition of the Board of Directors following Jeff Haywood's resignation.
- Review the full text of the termination agreement for any potential release of claims or future obligations.
- Check for any concurrent press releases or 10-Q/10-K filings that may contain related financial context.